Swinging the SWI/SNF complexes for cancer therapy
Trends in Pharmacological Sciences · 2025
DOI: 10.1016/j.tips.2025.07.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2025. Verfasst von Hongyan Jing und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anti-tumor Pharmacology, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Sha…. Hauptthemen laut MEDLINE: Neoplasms, Transcription Factors, Chromosomal Proteins, Non-Histone, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences, State Key Laboratory of Medicinal Chemical Biology.
Abstract (Originalsprache)
SWI/SNF chromatin remodeling complexes are essential epigenetic regulators that control chromatin accessibility and transcriptional programs. Alterations in SWI/SNF components are common across a wide spectrum of human cancers, driving tumorigenesis through diverse mechanisms. Increasing insights into the oncogenic roles of aberrant SWI/SNF complexes have spurred the development of novel therapeutic strategies. In this review, we integrate large-scale cancer genomic data towards understanding tumorigenesis driven by alterations in subunits of SWI/SNF complexes. We also evaluate strategies exploiting vulnerabilities in SWI/SNF-mutant cancers, including direct targeting of residual complex components and unique dependencies in critical cellular processes. Among them, one drug has been approved, and several others are in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Anti-tumor Pharmacology, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijin…
- Division of Anti-tumor Pharmacology, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- State Key Laboratory of Medicinal Chemical Biology
- Ministry of Science and Technology of the People's Republic of China
- National Key Research and Development Program of China
- State Key Laboratory of Drug Research
Zitieren
APA
Jing, H., Zhang, X., & Meng, L. (2025). Swinging the SWI/SNF complexes for cancer therapy. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2025.07.008
Vancouver
Jing H, Zhang X, Meng L. Swinging the SWI/SNF complexes for cancer therapy. Trends in Pharmacological Sciences. 2025. doi:10.1016/j.tips.2025.07.008
BibTeX
@article{Jing2025,
author = {Jing, Hongyan and Zhang, Xi and Meng, Linghua},
title = {Swinging the SWI/SNF complexes for cancer therapy},
journal = {Trends in Pharmacological Sciences},
year = {2025},
doi = {10.1016/j.tips.2025.07.008}
}
EUVIMED